Trials / Completed
CompletedNCT03748758
Evaluation of Safety of Repeated Doses of OP0201 Metered Dose Inhaler Compared to Placebo in Healthy Adult Volunteers
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 30 (actual)
- Sponsor
- Novus Therapeutics, Inc · Industry
- Sex
- All
- Age
- 18 Years – 50 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety and tolerability of two dose levels of OP0201 and placebo, when administered intranasally in healthy adults subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| COMBINATION_PRODUCT | Drug: OP0201 | Drug OP0201 |
| COMBINATION_PRODUCT | Drug: Placebo | Placebo |
Timeline
- Start date
- 2018-11-27
- Primary completion
- 2019-03-20
- Completion
- 2019-03-20
- First posted
- 2018-11-21
- Last updated
- 2020-02-25
- Results posted
- 2020-02-25
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT03748758. Inclusion in this directory is not an endorsement.